k8¿­·¢(Öйú)

ÕâÊÇÃèÊöÐÅÏ¢

ÍâÃÚÌåÑо¿

È«²¿·ÖÀà
ÁôÑÔ×Éѯ
Óë×îÐÂÏûÏ¢±£´æͬ²½
1/1
ä¯ÀÀÁ¿:
1000

ÍâÃÚÌåʾ×Ù·þÎñ

ÍâÃÚÌåÊÇϸ°û¼ä¹µÍ¨µÄÇÅÁº£¬Ó«¹â±ê¼ÇµÄÍâÃÚÌåÄܹ»¿ÉÊÓ»¯µØ×·×ÙÍâÃÚÌåÓëÊÜÌåϸ°û½áºÏÄËÖÁ½øÈëÊÜÌåϸ°ûÄÚ²¿ºóµÄ¶¯Ì¬·Ö²¼Çé¿ö£¬ÊÇ·¢ÏÖÍâÃÚÌåÏà¹ØÉúÎ﹦Äܱ³ºó×÷ÓûúÖƵÄÖØÒª»·½Ú¡£
ÁãÊÛ¼Û
0.0
Ôª
Êг¡¼Û
0.0
Ôª
ä¯ÀÀÁ¿:
1000
²úÆ·±àºÅ
ÊýÁ¿
-
+
¿â´æ:
0
Á¢¼´×Éѯ
1
²úÆ·ÃèÊö

       ¶ÔÓÚÍâÃÚÌ幦ÄÜÑо¿£¬Ò»°ãÏÈÒª¹Û²ìµ½ÍâÃÚÌå±»ÊÜÌåϸ°ûÉãÈ¡»òµ½´ïÄ¿µÄ×éÖ¯ºÍÆ÷¹Ùºó£¬ÔÙ¼ì²âÊÜÌåϸ°û¡¢×éÖ¯»òÆ÷¹ÙÖÐÏàÓ¦±íÐÍÖ¸±êÊÇ·ñ·¢Éú±ä»¯¡£Òò´Ë£¬ÍâÃÚÌå±ê¼ÇºÍʾ×ÙÊÇÍâÃÚÌ幦ÄÜÑо¿µÄ»ù´¡ºÍ¹Ø¼ü²½Öè¡£k8¿­·¢(Öйú)ÓµÓÐÍêÕûµÄ¼¼Êõƽ̨ºÍ·á¸»µÄ·þÎñ¾­Ñ飬¿ÉÒÔÌṩ¸÷ÖÖÍâÃÚÌå/µòÍöСÌåµÄ±ê¼Ç¡¢ÌåÍâϸ°ûÍÌÊÉ/Ó«¹â¹²¾Û½¹ºÍÌåÄÚС¶¯Îï³ÉÏñµÈÍâÃÚÌåʾ×Ù·þÎñ¡£

|  ÍâÃÚÌåʾ×Ù¼¼Êõ¼ò½é      

       Ä¿Ç°ÒÑ·¢±íµÄÍâÃÚÌåÎÄÕÂÖУ¬ÍâÃÚÌå´ó¶àʹÓÃÇ×Ö¬ÐÔȾÁϽøÐбê¼Ç£¬È¾ÁÏÔ­ÀíÊÇÇ×Ö¬ÐÔÓ«¹âĤȾÁϽ«Ö¬·¾×åµÄ³¤Î²°Í²åÈëÍâÃÚÌåµÄÖ¬ÖÊË«²ãÖк󷢳öÎȶ¨Çҳ־õÄÇ¿Ó«¹âÐźţ¨ÒԷǹ²¼Û·½Ê½Ç¶È룩£¬ÓÐÖúÓÚ¹Û²ìÍâÃÚÌåÓëÊÜÌåϸ°û/×éÖ¯/Æ÷¹ÙÖ®¼äµÄÏ໥×÷Óã¬ÔÚÌåÄÚºÍÌåÍⶼÓн϶àÓ¦Óá£

 

       ³£ÓõÄÇ×Ö¬ÐÔȾÁÏÖ÷Òª·ÖΪÁ½´óÀ࣬µÚÒ»ÀàÊÇPKH67£¨ÂÌÉ«Ó«¹â£©/PKH26£¨ºìÉ«Ó«¹â£©£¬µÚ¶þÀàÊÇDiϵÁеÄÇ×Ö¬ÐÔȾÁÏ£¬ÈçDiL£¨³ÈÉ«Ó«¹â£©¡¢DiO£¨ÂÌÉ«Ó«¹â£©¡¢DiD£¨ºìÉ«Ó«¹â£©¡¢DiR£¨ÉîºìÉ«Ó«¹â£©¡£ÕâЩȾÁÏ¿ÉÒÔÎȶ¨µÄÓëÍâÃÚÌåµÄĤ֬ÖÊÇø½áºÏ²¢·¢³öÓ«¹â£¬¿ÉÒÔÓÃÓÚÍâÃÚÌåµÄ¹¦ÄÜѧÑо¿¡£

 

1. Ç×Ö¬ÐÔȾÁÏ:PKH-67£¨ÂÌÉ«Ó«¹â£©/PKH-26£¨ºìÉ«Ó«¹â£©

      PKHϵÁÐȾÁϾßÓж¾ÐÔ½ÏС£¬Ó«¹â±³¾°µÍ£¬Ö¬ÈÜÐԸߣ¬Äܹ»´©Í¸Ï¸°ûĤ£¬Ó«¹âÇ¿¶øÎȶ¨µÈÌص㡣ÆäÖÐPKH67µÄÌåÄÚÓ«¹â°ëË¥ÆÚΪ10-12Ì죬Ïà±ÈÓÚPKH-67£¬PKH-26¾ßÓиü³¤µÄ°ëË¥ÆÚ£¬ÓÉÓÚÆäÓ«¹âÎȶ¨ÐÔ½ÏÇ¿£¬ÔÚ±ê¼ÇÑо¿ÖÜÆÚ³¬¹ýÒ»ÖÜʱ£¬ÌرðÊÊÓÃÓÚÍâÃÚÌåʾ×ÙÑо¿¡£

2. Ç×Ö¬ÐÔôÊ»¨ÇàȾÁÏ

       DiL,DiR,DiO,DiDÊÇһϵÁÐÇ×Ö¬ÐÔµÄÓ«¹âȾÁÏ£¬¿ÉÒÔÓÃÀ´È¾Ï¸°ûĤºÍÆäËüÖ¬ÈÜÐÔÉúÎï½á¹¹¡£ÕâЩ»·¾³Ãô¸ÐÐÔÓ«¹âȾÁÏÔÚ½øÈëϸ°ûĤ֮ǰӫ¹â·Ç³£Èõ£¬µ±Óëϸ°ûĤ½áºÏºóÆäÓ«¹âÇ¿¶È´ó´óÔöÇ¿£¬Æä¾ßÓÐÏû¹âϵÊý¸ß¡¢¼«ÐÔÒÀÀµÐÔ¡¢¼¤·¢Ì¬ÊÙÃü¶ÌµÈÌصã¡£ÈçDiR ÊÇÒ»ÖÖÇ×Ö¬ÐÔ½üºìÍâÓ«¹âĤȾÁÏ£¬¿É´©Í¸Ï¸°ûºÍ×éÖ¯£¬ÔÚ»îÌå³ÉÏñÖÐÓÃÀ´Ê¾×Ù¡£Í¨¹ýÁ½¸ö18-̼Á´²åÈ뵽֬Ĥ£¬ÔÚË®ÖÐ΢ÈõÓ«¹â£¬µ±²ôÈëĤÖÐʱ¾ßÓиßÓ«¹âºÍÏ൱ºÃµÄ¹âÎȶ¨ÐÔ£¬ÊµÏÖÌØÒìÐÔ¡¢Îȶ¨µÄĤȾɫ¡£´ËÍ⣬½üºìÍâÓ«¹â³ÉÏñµÄ±³¾°¸É¾»£¬¿ÉÒÔ±ÜÃâÉúÎïÌåÄÚÔڿɼû¹â·¶Î§ÄÚ×Ô·¢Ó«¹âÔì³ÉµÄ±³¾°¸ÉÈÅ¡£

 

|   ÍâÃÚÌåʾ×Ù²úÆ·

|   ÍâÃÚÌåʾ×ÙÁ÷³Ì      

 

|   Ïà¹ØÎÄÏ×

[1]. Chen L, Wang Y, Li S, et al. Exosomes Derived from GDNF-Modified Human Adipose Mesenchymal Stem Cells Ameliorate Peritubular Capillary Loss in Tubulointerstitial Fibrosis by Activating the SIRT1/eNOS Signaling Pathway. Theranostics. 2020 Jul 25;10(20):9425-9442.£¨ÐìÖÝÒ½¿Æ´óѧ¸½ÊôÒ½Ôº£©IF=12.4

[2]. Ren R, Sun H, Ma C, et al. Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment. Cell Biosci. 2019 Aug 6;9:62.£¨°²»ÕÒ½¿Æ´óѧµÚÒ»¸½ÊôÒ½Ôº£©IF=7.5

[3]. Yoshida K, Tsuda M, Matsumoto R, et al. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer. Cancer Sci. 2019 Jul;110(7):2119-2132.£¨±±º£µÀ´óѧҽѧ²¿£©

[4]. Liu Hao,Marquez Rebecca T,Wu Xiaoqing et al. A non-intrusive evaluation method for tumor-targeting characteristics of nanomedicines based on in vivo near-infrared fluorescence imaging. J Mater Chem B, 2019, 7: 4751-4757.£¨Î÷ÄÏÒ½¿Æ´óѧҩѧԺ£©IF=7.0

[5]. Tang Yixuan,Wang Xiaoyou,Li Jie et al. Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a "Don't-Eat-Us" Strategy. ACS Nano, 2019, 13: 13015-13026.£¨Î÷ÄÏ´óѧҩѧԺ£©IF=17.1

[6]. Wiklander O P B, Nordin J Z, O"Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015 Apr 20;4:26316.£¨¿¨ÂÞÁÖ˹¿¨Ò½Ñ§ÔºÊµÑéÊÒ£©IF=16.0

 

¹Ø¼ü´Ê:
ÍâÃÚÌå¡¢ÍâÃÚÌåʾ×Ù¡¢ÍâÃÚÌ幦ÄÜʵÑé¡¢ÍâÃÚÌåÌáÈ¡
δÕÒµ½ÏàÓ¦²ÎÊý×飬ÇëÓÚºǫ́ÊôÐÔÄ£°åÖÐÌí¼Ó
ÏÂÒ»¸ö
k8¿­·¢(Öйú)

µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã

µç»°£º400-869-2936£¬021-33968791

ÓÊÏ䣺support@wayenbiotech.com

´«Õ棺021-33938792

QQ£º2120485725

Õ½ÂÔºÏ×÷

Õ½ÂÔºÏ×÷

·¢²¼Ê±¼ä£º2021-08-11 17:21:10

|    Full Moon    |    RayBiotech    |    CDI    |    IZON    |    Bio-Rad    |    R&D Systems    |    IsoPlexis    |    ÄÏÄ£ÉúÎï    |    Å·Ò×ÉúÎï    |    ÆäÃ÷ÐÅÏ¢    |    ÃÀ¼ªÉúÎï    |    ÂóÌØ»æÆ×    | 

 

Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿­·¢(Öйú)Ô­´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿­·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£

רÀû´úÂë

·¢²¼Ê±¼ä£º2023-06-09 17:38:30
Copyright @ 2021 ÉϺ£k8¿­·¢(Öйú)Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ °æȨËùÓÐ
Record »¦ICP±¸2022031428ºÅ-1
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ÉϺ£
ËÑË÷
ËÑË÷
¹Ø±Õ
¿Í»§ÁôÑÔ
ÑéÖ¤Âë